Form 4: CompoSecure Director John D. Cote Granted Stock Options Valued at $13.68 Per Share

CompoSecure, Inc. (CMPO) Director and 10% Owner John D. Cote was granted 21,074 stock options with an exercise price of $13.68 per share, vesting over four years.

Summary

• John D. Cote, a Director and 10% Owner of CompoSecure, Inc. (CMPO), was granted 21,074 stock options.
• The options have an exercise price of $13.68 per share.
• The grant date for these options was May 28, 2025.
• The options will vest in equal annual installments of 25% on May 28, 2026, and on the first, second, and third anniversaries thereafter (May 28, 2027, May 28, 2028, and May 28, 2029).
• The options expire on May 28, 2035.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While a stock option grant is a routine compensation event, it signifies continued commitment from a significant insider (Director and 10% Owner) and aligns their incentives with the company's future stock performance. There are no negative operational or financial disclosures.

Positives

• The grant of stock options to a Director and 10% Owner aligns management's interests with long-term shareholder value, as the options gain value only if the stock price increases above the exercise price.
• The vesting schedule encourages long-term commitment and retention of key personnel.

Negatives

• The issuance of new stock options could lead to potential dilution if exercised, although this is a standard component of executive compensation.

Future Outlook

NA

Industry Context

This Form 4 filing reports a standard equity compensation grant to a director and significant shareholder, which is a common practice across various industries to incentivize long-term performance and align executive interests with shareholder returns. It does not provide broader industry trends.

Stakeholder Impact

• Shareholders: The grant aligns the interests of a significant insider with shareholders, as the options' value is tied to stock price appreciation. However, potential future exercise could lead to minor dilution.
• Management/Employees: This grant is part of the compensation structure for a key executive, incentivizing long-term performance.

Next Steps

• The stock options will vest in four equal annual installments, with the first vesting on May 28, 2026.
• John D. Cote may choose to exercise these options at any point after they vest and before their expiration date of May 28, 2035, assuming the stock price is above the exercise price of $13.68.

Key Dates

Recommendation

Keywords

CompoSecure, CMPO, Stock Options, Insider Transaction, Form 4, John D. Cote, Director Compensation, Equity Grant, Beneficial Ownership